|
Match
|
Document |
Document Title |
|
|
5331009 |
Pharmaceutical compositions for treating adrenoleukodystrophy
A composition for the treatment of adrenoleukodystrophy comprises a mixture of erucic acid and less than 20% of C20:1, in the absence of any C24:0 and C26:0 acids (all the acids being as such or in...
|
|
|
5306729 |
Method for effecting vasodilation with monoglycerides
The invention provides a novel method of effecting vasodilation in a warm-blooded animal in need of such treatment and involves administering to a warm-blooded animal an effective amount of a...
|
|
|
5288624 |
Cercosporal fungicide compositions and methods of use
The present invention relates to a funcidally active principle (fungicidal agent) obtainable by cultivation of fungi of the genus Phaeoramularia or Cercospora. The principle can be used for...
|
|
|
5284876 |
Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents
This invention pertains to a method for treating a subject for Tardive Dyskinesia by administering a dopaminergic agent to the subject such that the dopaminergic agent enters the brain or by...
|
|
|
5260336 |
Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
Disclosed is a method of minimizing the effects of a catabolic illness in an individual by administering to the individual a diet which is controlled in the type of fatty acid intake. The diet...
|
|
|
5256694 |
Diarylacetylenes, their preparation and their use
Novel diarylacetylenes of the formula I ##STR1## where A, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 have the meanings stated in the description, are useful for the treatment of disorders.
|
|
|
5238961 |
PGF 1-alcohols and their use as ocular hypotensives
The invention relates to the use of alcohol derivatives of F-type prostaglandins as ocular hypotensives. The PGF derivatives used in accordance with the invention are encompassed by the following...
|
|
|
5232947 |
Oxamic acid compounds and pharmaceutical composition for use in improvement of damaged cerebral functions of brain
New N,N-di-alkyl- or alkenyl-substituted derivatives of oxamic acid of which the two alkyl or alkenyl groups are different from each other are now produced and found to exhibit the cerebral...
|
|
|
5231085 |
Compositions and methods for the enhancement of host defense mechanisms
The invention provides immunostimulatory compositions comprising an aggregate immunostimulatory amount of a) a compound associated with the synthesis of polyamines, b) a nucleobase source, ...
|
|
|
5227403 |
Fats and oils having superior digestibility and absorptivity
A nutrient comprising fats and oils having superior digestibility and absorptivity are provided, which fats and oils are comprised of at least one triglyceride having fatty acids of C 8 to C 14 ...
|
|
|
5225447 |
Composition and method for the treatment of sickle cell anemia
The major component of the carbonate fraction of free acids extractable from alfalfa has shown excellent control of symptoms in patients with sickle cell disease. Its structure has been established...
|
|
|
5225429 |
Fluorinated arachidonic acid derivatives
Fluorinated arachidonic derivatives are 5-lipoxygenase inhibitors which have the useful pharmacologic activity as antiallergy and anti-inflammatory agents and are useful for treating, for example,...
|
|
|
5219887 |
Disinfecting shampoo composition for animals
A shampoo composition and related process for disinfecting, cleansing, conditioning, and moisturizing the skin and coat of an animal. The composition involves the use of a fatty acid monoester of a...
|
|
|
5198012 |
Phosphate activators for cyclohexenone herbicides
A biocide composition comprises an effective amount of a biocide and an effective amount of a biocide activator selected from the group consisting of an alkyl phosphate, an alkenyl phosphate, a...
|
|
|
5196198 |
Parenteral nutrition product
Parenteral nutritional compositions are described that contain a source of gamma-linolenic acid. A method of parenterally administering these compositions is also disclosed.
|
|
|
5169867 |
Hydroxylamine compounds
Compounds of formula ##STR1## wherein R 1 is amino or is a radical ##STR2## wherein R 3 is lower alkyl, hydroxy-lower alkyl, lower alkoxy-lower alkyl, carboxy, lower alkoxycarbonyl, phenyl,...
|
|
|
RE34075 |
Dermal uses of trans-retinoids for the treatment of cancer
The dermal use of non-irritating retinoids such as the esters and amides of 13-cis and 13-trans-retinoic acid for effecting the reduction and reversal of photoaging and skin cancer is disclosed.
|
|
|
5145611 |
Carboxylic acid derivatives, and pharmaceutical compositions containing them
Carboxylic acid derivatives of the formula ##STR1## R 1 is alkoxy, alkylthio, alkylsulphinyl, alkulsulphonyl, alkylamino, cycloalkyl, or cycloalkoxy or optionally substituted aryl, aryloxy,...
|
|
|
5137734 |
Angiogenic monoglycerides
Monoglycerides of the formula: ##STR1## wherein R is an aliphatic hydrocarbyl moiety of 2-10 C, straight chain or branched, saturated or unsaturated, and optionally substituted with one or more...
|
|
|
5124083 |
3-substituted and 3,3-disubstituted 4-oxoretinoic acids and their esters
There are disclosed 3-substituted and 3,3-disubstituted all-trans-4-oxoretinoic acids and 3-substituted and 3,3-disubstituted 13-cis-4-oxoretinoic acids and their lower alkyl esters.
|
|
|
5124356 |
Dermal uses of trans-retinoids for the treatment of photoaging
The dermal use of non-irritating retinoids such as the esters and amides of 13-cis and 13-trans-retinoic acid for effecting the reduction and reversal of photoaging and skin cancer is disclosed.
|
|
|
5118493 |
Composition having reduced nephrotoxocity comprising a fatty acid containing component and cyclosporine
Compositions comprising cyclosporine in combination with a vehicle comprising a fatty acid component comprising a fatty acid of the omega-3 or a pharmacologically acceptable salt thereof. Methods...
|
|
|
5118681 |
S-beta-dicarbonyl substituted beta-thioacrylamide biocides and fungicides
S-beta-dicarbonyl substituted beta-thioacrylamide compounds have been discovered to be useful as biocides and fungicides. Compositions comprising the compound and isothiazolin-3-ones and/or...
|
|
|
RE33885 |
Compositions for inhibiting absorption of cholesterol
Polyol fatty acid polyesters having at least four fatty acid ester groups are fortified with fat-soluble vitamins and used in pharmaceutical compositions for treating and/or preventing...
|
|
|
5102912 |
Hydroxyoctadecadienic acid for the treatment of estrogen-dependent disease
This invention describes the use of a hydroxyoctadecadienic acid, its acid oxidized to keto form or the ester derivatives of the acids, where the ester derivatives are low esters with 1 to 4 carbon...
|
|
|
5098931 |
7-substituted HMG-CoA reductase inhibitors
Novel HMG-CoA reductase inhibitors are useful as antihypercholesterolemic agents and are represented by structural formulae (I) and (II): ##STR1##
|
|
|
5093044 |
Triglyercide nutrient for humans and animals
The invention relates to a nutrient for humans and animals, which is characterized in that the nutrient contains at least one non-readily water-soluble glyceride of at least one keto acid or...
|
|
|
5090995 |
Aqueous biocide composition stabilized by phthalic acid esters
Disclosed is an agricultural chemical composition in the form of an aqueous suspension, which comprises fine particles of a water-insoluble physiologically active substance having a melting point...
|
|
|
5089492 |
Pharmaceuticals and dietetics containing acylamino acid derivatives
Acylamino carboxylic acid derivatives corresponding to the formula I ##STR1## in which the groups R 1 , R 2 , R 3 , Z 1 and Z 2 represent functional groups specified in the claims. The acylamino...
|
|
|
5081105 |
Method of treating cancer using structured lipids
Disclosed is a method of treating cancer using nutritional support therapy by administration of a structured lipid containing both ω3 fatty acids and medium-chain fatty acids. The therapy may be...
|
|
|
5071843 |
Combination of 2-substituted carbapenems with dipeptidase inhibitors
A combination of a carbapenem of the formula: ##STR1## where R is H or CH 3 and R 1 is ##STR2## with a renal dipeptidase inhibitor is disclosed.
|
|
|
5070104 |
Methods of chelating metal and novel compositions therefor
A method of chelating a metal in solution comprise adding to the solution a safe and effective amount of an active form of CLA. Pharmaceutical preparations for practice of the method in vivo are...
|
|
|
5066482 |
Compositions and method for controlling cockroaches
The invention relates to novel compositions and methods for controlling cockroach populations using the (S)-(+) enantiomer of hydroprene.
|
|
|
5066427 |
Eicosatriynoic acid esters and their application in pharmaceutical and cosmetic practice
Compound, corresponding to the formula C 8 H 17 (C.tbd.C--CH 2 ) 3 CH 2 CH 2 COR (I) in which R is a C 1 -C 8 lower alkoxy or C 4 -C 6 cycloaly group, substituted with one or more...
|
|
|
5059622 |
Method for reducing blood pressure levels in hypertensive persons
The modulation of prostaglandin levels can be realized through the dietary intake of specified ratios of activated Omega 6 essentially fatty acids when combined with the appropriate amount of...
|
|
|
5049584 |
Dermal uses of cis-retinoids for the treatment of cancer
The dermal use of non-irritating retinoids such as the esters and amides of 13-cis and 13-trans-retinoic acid for effecting the reduction and reversal of photoaging and skin cancer is disclosed.
|
|
|
5043356 |
Composition and method for rejuvenating skin using vitamin A propionate
Topically applied compositions for the accelerated rejuvenation of skin and an associated method of skin care treatment are disclosed utilizing vitamin A propionate of the general formula ##STR1##...
|
|
|
5034414 |
Liquid emulsion for transfusion
A nutritional liquid emulsion for transfusion comprising of a mixture of fatty acid esters containing 20-22 carbon atoms which are contained in a purified fish oil selected from the group...
|
|
|
5028612 |
Method for treating emotional numbness
An opiate antagonist or a pharmaceutically acceptable salt thereof is used to treat emotional numbness associated with Post Traumatic Stress Disorder and other psychopathologic conditions.
|
|
|
5026548 |
Surfactant
A surfactant for use as a viscosity reducing agent in chocolate, or an emulsifier, surfactant or foam stabilizer in the food and other industries is produced by extracting oats using an alcohol...
|
|
|
5013719 |
Method of effecting immunosuppression
This invention relates to a method of effecting immunosuppression in a patient in need thereof, comprising co-administering to said patient an effective amount of an immunosuppressive agent,...
|
|
|
5002971 |
Method and agent for controlling the peach twig borer
Agent for controlling the peach twig borer, Anarsia lineatella, by the confusion technique containing a mixture of E5-decen-1-ol (I), E5-decen-1-yl acetate (II) and Z5-decen-1-ol (III) and...
|
|
|
4999346 |
Novel composition and process for control of cockroach population
Insecticidal composition comprising propetamphos and hydroprene is useful for safe, fast, complete and long lasting control of cockroach populations. A method for control of the cockroach...
|
|
|
4997851 |
Antiviral and antibacterial activity of fatty acids and monoglycerides
This invention is directed to antiviral and antibacterial activity of fatty acids and monoglycerides. More particularly, this invention is directed to the inactivation of enveloped viruses and the...
|
|
|
4981873 |
Substituted sulphonamides, pharmaceuticals thereof and methods of using them
The present invention concerns compounds of the formula: ##STR1## where R 1 is an alkyl or alkenyl radical containing up to 6 carbon atoms, a cycloalkyl radical containing 3 to 7 carbon atoms, an...
|
|
|
4981844 |
Method to improve immune response and resistance to infection following surgery by diet composition
The immune response of a patient can be improved pre-operatively by altering the diet of a patient. When 20 to about 80% of the calories in a diet are from linoleic acid which is an omega 6 fatty...
|
|
|
4966915 |
L-dopa derivatives or their acid addition salts, process for producing same and their use
An L-dopa derivative represented by formula (I) ##STR1## wherein one of R 1 and R 2 denotes a hydrogen atom and the other denotes a group of formula R--CO-- in which R denotes an alkyl, alkenyl,...
|
|
|
4954525 |
Method of treating skin diseases
Skin diseases with keratinization and allergic or inflammatory skin diseases are treated by orally or parenterally administering to an adult human patient from 40 mg to 4 g/day of a polyprenyl...
|
|
|
4952580 |
Pesticidal polyhaloalkene derivatives
Polyhaloalkene compounds of the formula: ##STR1## wherein X is sulfur, oxygen, or nitrogen, Y 1 and Y 2 are fluorine, Z is hydrogen or the same as Y 1 and Y 2 , and n is 1-4; provided that: ...
|
|
|
4939174 |
Appetite suppression with dopamine-fatty acid conjugates
The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be...
|